Tech Company Financing Transactions
Novira Therapeutics Funding Round
5AM Ventures, Canaan Partners and BioAdvance Ventures participated in a $23 million Series A funding round for Novira Therapeutics. The round was announced by the company on 8/23/2012.
5AM Ventures (Lead Investor) (Scott Rocklage)
Canaan Partners (Lead Investor) (Timothy Shannon)
Delaware Crossing Investor Group
Doylestown, PA 18902
Browse more venture capital transactions:
Prev: 8/23/2012: Exosome Diagnostics venture capital transaction
Next: 8/23/2012: PLAiR venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs